Bovine viral diarrhea virus (BVDV) has been detected in peripheral blood 41 mononuclear cells (PBMCs) of immunocompetent animals, not being clear whether the 42 development of a specific humoral immune response can prevent BVDV infection. The aim 43 of this study was to evaluate the ability of non-cytopathic BVDV to replicate and produce 44 infectious virus in PBMCs from calves pre-infected with BVDV and to elucidate the 45 immunomodulatory effect of BVDV on these cells in an in vitro model. Quantification of 46 virus was by quantitative PCR, while its replicative capacity and shedding into the 47 extracellular environment was evaluated by viral titration. Apoptosis was assessed by flow 48 cytometry analysis of annexin V and propidium iodide, and by expression of caspase-3/7. 49
. BVDV can lead to acute infection in susceptible immunocompetent cattle, 66 persistent infection, or chronic infection in immune-privileged sites [2] . The most important 67 consequences for herds occur when a non-cytopathic (ncp) BVDV strain infects a susceptible 68 cow early in gestation; the fetus becomes immunotolerant to this infecting viral strain and 69 remains persistently infected (PI), shedding the virus throughout its lifetime and serving as a 70 reservoir of infection for naïve animals [3] . 71
The immunosuppressive effect of BVDV is attributed to its ability to infect T and B 72 lymphocytes and monocytes, the main components in percentage terms of peripheral blood 73 mononuclear cell (PBMC) populations [4, 5] . Infection of PBMCs disrupts the normal 74 mechanisms of immune stimulation, leading to immune evasion and chronic infection [6] . In 75 general, ncp BVDV strains induce large decreases in white blood cell counts [7, 8] , as well as 76 the expression of major histocompatibility complex (MHC) type II and CD80/86 in antigen-77 presenting cells (APCs) [9, 10, 11] . Furthermore, T cell proliferation response in ncp BVDV 78 infections is slower and less prolonged than in cytopathic (cp) BVDV [12, 13, 14] . 79
There are also many studies measuring antibody neutralization and cross-80 neutralization of BVDV strains to prevent disease after vaccination [15] . An in vitro study 81 demonstrated that lymphocytes in cattle that had been vaccinated against BVDV were less 82 efficiently infected than in naïve animals [16] . However, BVDV antigens have been detected 83 in PBMCs in seropositive animals with the presence of neutralizing antibodies [17, 18] (FCS), L-glutamine 2mM, antibiotics and antifungal agents] (Euroclone). The VN titer for 112 each serum was the highest dilution at which the virus was neutralized in 50% of the wells 113 [22] . Animals were regarded as seronegative when no neutralization was observed at the 114 lowest dilution (1:4) . 115
At the time of the study, naïve animals were confirmed to be free from both BVDV 116 antigens and antibodies, while animals pre-infected with BVDV through exposure to the PI 117 calf were confirmed to be BVDV antigen-free and VN antibody titers to BVDV-1 were >128. 118
The leukocyte profile was analyzed with the Sysmex XT-2000iV hematology analyzer, using 119 specific settings for bovine blood (Sysmex Corporation, Kobe, Japan). Total leukocyte and 120 platelet counts were within the normal range for bovine ( 
Cell separation, culture and infection of PBMCs

Flow cytometry 191
PBMCs from both groups were harvested at 18, 24 and 48 hpi, divided into aliquots of 192 2x10 5 cells/100μl and incubated for 30 min at RT with optimally diluted mouse monoclonal 193 antibodies (Table 2) 
BVDV replication in PBMCs 241
BVDV RNA was not detected in the PBMCs or culture supernatants from the mock-242 inoculated samples of the two animal groups. There was scant detection of intracellular 243 BVDV in PBMCs in both animal groups during this experiment, with slightly higher rates 244 observed only at 48 hpi. Nonetheless, at 18 and 24 hpi, the quantity of BVDV RNA in the 245 culture supernatants of PBMCs from pre-infected animals was significantly greater than in 246 PBMCs from naïve animals (P0.0001) (Figure 1) . 247
The ability of BVDV to shed infectious virus in PBMCs to the extracellular 248 environment was evaluated by measuring viral titers in the culture supernatants. 249
Immunolabeling did not detect the presence of BVDV in MDBK cells treated with culture 250 supernatants from mock-infected PBMCs. Throughout the experiment, PBMCs culture 251 supernatants from both naïve and pre-infected groups showed consistently low extracellular 252 BVDV titers, with a significant difference (P<0.05) between groups at 48 hpi (Figure 2) . 253 254
Ability of BVDV to stimulate T-cell responses 255
There was no observable evidence that BVDV had a statistically significant down-256 regulatory effect on the expression of CD14+ or CD11b+, although there seemed to be a 257 downregulated expression of co-stimulatory molecules (CD14+) CD80+ in the monocyte 258 populations of animals pre-infected with BVDV compared with naïve animals (Figure 3) . 259
After BVDV infection, no statistically significant differences were found in the 260 percentages of T lymphocytes (CD4+ or CD8+ subpopulations), B-lymphocytes or in the 261 expression of the CD25 activation marker in the PBMCs of the two animal groups, or in the 262 same group over the whole study period (Figure 4) . Our results showed that PBMCs from both naïve animals and those pre-infected with BVDV 277 were efficiently infected in vitro with BVDV in the conditions tested. PBMCs from BVDV 278 pre-infected animals were more susceptible to BVDV infection in vitro and presented a 279 higher ability to release infectious BVDV into the extracellular environment. This could 280 represent a survival strategy of ncp BVDV strains, enabling the BVDV to be more readily 281 disseminated and to persist in the host cell population [14] . However, our results did not 282 agree with those reported by Lucchini et al. [19] , who observed lower BVDV titers in 283 PBMCs cultures from immunized animals than from naïve ones, although the immunized 284 animals were incompletely protected against heterologous BVDV strains. These findings 285 suggest the involvement of a cell-mediated immune response able to control the BVDV load, 286 and also that re-infections should be considered for their potential impact on vaccination 287
programs. 288
Maintenance of the percentage of monocytes in naïve and BVDV-pre-infected groups 289 was consistent with other in vitro studies showing that infection with a ncp strain did not kill 290 vivo [9] and in vitro [10, 11] to no effect on surface expression [6] . In our study, while not 297 significant, downregulation of CD80 was observed on monocytes from both BVDV-infected 298 groups, suggesting that a higher infectious dose or prolonged exposure might induce more 299 obvious changes. No significant changes in MHC-II were observed after ncp BVDV 300 infection, which coincides with some studies carried out on monocytes [6], but contrasts with 301 other ones that reported an inhibitory effect on MHC class II expression by ncp BVDV 302 [10, 11] . 303
The lack of change in the percentage of T lymphocytes after in vitro BVDV infection 304 contrasts with the significant decreases observed in in vivo ncp BVDV infections [8, 30] . The 305 absence of changes in our study could indicate that T lymphocytes do not proliferate in 306 response to antigen presentation of the virus, which might be explained by the unchanged 307 percentage of (CD4+) CD25+ subpopulation cells of both animal groups [31] . In the BVDV-308 seropositive calves, these results contrast with the CD25 upregulation observed in other trials 309 following infection or vaccination [32, 33] . 310
The reported effects on circulating B-lymphocytes during in vivo infections with 311 BVDV vary from a decreased number to no change [9, 30] , possibly due to differences in 312 viral strains. No changes in the percentage of B lymphocytes were observed in this study, 313 which contrasts with the affection in circulating B-cells or in lymphoid follicles in in vivo 314 BVDV infections with the same strain [8, 26] . These studies showed that activation of the 315 initiator caspase-8 seems to play a major role in lymphocyte apoptosis, suggesting that this 316 could be caused by an indirect mechanism mediated by pro-apoptotic cytokines released by 317 macrophages [25] . In our study, PBMCs from the pre-infected group presented significant 
